310 related articles for article (PubMed ID: 19364832)
1. Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine.
Leatham MP; Banerjee S; Autieri SM; Mercado-Lubo R; Conway T; Cohen PS
Infect Immun; 2009 Jul; 77(7):2876-86. PubMed ID: 19364832
[TBL] [Abstract][Full Text] [Related]
2. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine.
Maltby R; Leatham-Jensen MP; Gibson T; Cohen PS; Conway T
PLoS One; 2013; 8(1):e53957. PubMed ID: 23349773
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli EDL933 requires gluconeogenic nutrients to successfully colonize the intestines of streptomycin-treated mice precolonized with E. coli Nissle 1917.
Schinner SA; Mokszycki ME; Adediran J; Leatham-Jensen M; Conway T; Cohen PS
Infect Immun; 2015 May; 83(5):1983-91. PubMed ID: 25733524
[TBL] [Abstract][Full Text] [Related]
4. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine.
Miranda RL; Conway T; Leatham MP; Chang DE; Norris WE; Allen JH; Stevenson SJ; Laux DC; Cohen PS
Infect Immun; 2004 Mar; 72(3):1666-76. PubMed ID: 14977974
[TBL] [Abstract][Full Text] [Related]
5. Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine.
Fabich AJ; Jones SA; Chowdhury FZ; Cernosek A; Anderson A; Smalley D; McHargue JW; Hightower GA; Smith JT; Autieri SM; Leatham MP; Lins JJ; Allen RL; Laux DC; Cohen PS; Conway T
Infect Immun; 2008 Mar; 76(3):1143-52. PubMed ID: 18180286
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli pathotypes occupy distinct niches in the mouse intestine.
Meador JP; Caldwell ME; Cohen PS; Conway T
Infect Immun; 2014 May; 82(5):1931-8. PubMed ID: 24566621
[TBL] [Abstract][Full Text] [Related]
7. An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic.
Adediran J; Leatham-Jensen MP; Mokszycki ME; Frimodt-Møller J; Krogfelt KA; Kazmierczak K; Kenney LJ; Conway T; Cohen PS
Infect Immun; 2014 Feb; 82(2):670-82. PubMed ID: 24478082
[TBL] [Abstract][Full Text] [Related]
8. L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium.
Autieri SM; Lins JJ; Leatham MP; Laux DC; Conway T; Cohen PS
Infect Immun; 2007 Nov; 75(11):5465-75. PubMed ID: 17709419
[TBL] [Abstract][Full Text] [Related]
9. Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine.
Petersen AM; Schjørring S; Gerstrøm SC; Krogfelt KA
PLoS One; 2011; 6(8):e22823. PubMed ID: 21853049
[TBL] [Abstract][Full Text] [Related]
10. Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria.
Zhao T; Doyle MP; Harmon BG; Brown CA; Mueller PO; Parks AH
J Clin Microbiol; 1998 Mar; 36(3):641-7. PubMed ID: 9508288
[TBL] [Abstract][Full Text] [Related]
11. Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids.
Pradhan S; Weiss AA
mBio; 2020 Jul; 11(4):. PubMed ID: 32636253
[No Abstract] [Full Text] [Related]
12. A Simple
Mokszycki ME; Leatham-Jensen M; Steffensen JL; Zhang Y; Krogfelt KA; Caldwell ME; Conway T; Cohen PS
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30291119
[TBL] [Abstract][Full Text] [Related]
13. Measurements of fitness and competition in commensal Escherichia coli and E. coli O157:H7 strains.
Durso LM; Smith D; Hutkins RW
Appl Environ Microbiol; 2004 Nov; 70(11):6466-72. PubMed ID: 15528507
[TBL] [Abstract][Full Text] [Related]
14. The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota.
Leatham-Jensen MP; Frimodt-Møller J; Adediran J; Mokszycki ME; Banner ME; Caughron JE; Krogfelt KA; Conway T; Cohen PS
Infect Immun; 2012 May; 80(5):1716-27. PubMed ID: 22392928
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
16. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus.
Wadolkowski EA; Laux DC; Cohen PS
Infect Immun; 1988 May; 56(5):1030-5. PubMed ID: 3281898
[TBL] [Abstract][Full Text] [Related]
17. Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.
McCormick BA; Franklin DP; Laux DC; Cohen PS
Infect Immun; 1989 Oct; 57(10):3022-9. PubMed ID: 2570752
[TBL] [Abstract][Full Text] [Related]
18. Neither motility nor chemotaxis plays a role in the ability of Escherichia coli F-18 to colonize the streptomycin-treated mouse large intestine.
McCormick BA; Laux DC; Cohen PS
Infect Immun; 1990 Sep; 58(9):2957-61. PubMed ID: 2201640
[TBL] [Abstract][Full Text] [Related]
19. In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant.
Nevola JJ; Laux DC; Cohen PS
Infect Immun; 1987 Dec; 55(12):2884-90. PubMed ID: 3316026
[TBL] [Abstract][Full Text] [Related]
20. Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7.
Momose Y; Hirayama K; Itoh K
Antonie Van Leeuwenhoek; 2008 Aug; 94(2):165-71. PubMed ID: 18247153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
